Ventricular assist devices as destination treatment. About one case
نویسندگان
چکیده
منابع مشابه
Left ventricular assist devices as destination therapy.
Although an estimated 16,500 Americans annually could benefit from a heart transplant, in 1999 only 2184 heart transplants were performed in the United States. These statistics emphasize the severity of the shortage of available hearts for transplantation. Circulatory support provided by an implantable Left Ventricular Assist Device (LVAD) that meets Food and Drug Administration approval as des...
متن کاملCost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.
BACKGROUND Continuous-flow left ventricular assist devices (LVADs) have become the dominant devices for mechanical circulatory support, but their cost-effectiveness is undetermined. This study assessed the cost-effectiveness of continuous-flow devices for destination therapy versus optimal medical management in advanced heart failure and compared the results with previous estimates for pulsatil...
متن کاملPalliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy.
OBJECTIVE To assess the benefit of proactive palliative medicine consultation for delineation of goals of care and quality-of-life preferences before implantation of left ventricular assist devices as destination therapy (DT). PATIENTS AND METHODS We retrospectively reviewed the cases of patients who received DT between January 15, 2009, and January 1, 2010. RESULTS Of 19 patients identifie...
متن کاملLeft ventricular assist devices as destination therapy for end-stage heart failure.
In the therapy of advanced heart failure, left ventricular assist devices represent an exciting new option. The role of mechanical circulatory support is currently limited predominantly by factors related to device durability. The population for whom mechanical circulatory support can be considered as permanent therapy is defined by those for whom improvement in survival and clinical function i...
متن کاملModeling payback from research into the efficacy of left-ventricular assist devices as destination therapy.
OBJECTIVES Ongoing developments in design have improved the outlook for left-ventricular assist device (LVAD) implantation as a therapy in end-stage heart failure. Nevertheless, early cost-effectiveness assessments, based on first-generation devices, have not been encouraging. Against this background, we set out (i) to examine the survival benefit that LVADs would need to generate before they c...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Gaceta de M�xico
سال: 2019
ISSN: 0016-3813
DOI: 10.24875/gmm.m19000254